Gyre Therapeutics, Inc. (GYRE)
6.775
+0.08
(+1.27%)
USD |
NASDAQ |
Sep 16, 11:05
Gyre Therapeutics Market Cap : 718.38M for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 709.37M |
| September 14, 2026 | 709.37M |
| September 11, 2026 | 713.61M |
| September 10, 2026 | 714.67M |
| September 09, 2026 | 736.93M |
| September 08, 2026 | 760.26M |
| September 04, 2026 | 727.39M |
| September 03, 2026 | 682.86M |
| September 02, 2026 | 674.38M |
| September 01, 2026 | 686.04M |
| August 31, 2026 | 696.64M |
| August 28, 2026 | 698.76M |
| August 27, 2026 | 708.31M |
| August 26, 2026 | 705.12M |
| August 25, 2026 | 708.31M |
| August 24, 2026 | 682.86M |
| August 21, 2026 | 732.69M |
| August 20, 2026 | 744.36M |
| August 19, 2026 | 758.14M |
| August 18, 2026 | 740.12M |
| August 17, 2026 | 722.09M |
| August 14, 2026 | 708.31M |
| August 13, 2026 | 693.46M |
| August 12, 2026 | 706.19M |
| August 11, 2026 | 704.06M |
| Date | Value |
|---|---|
| August 10, 2026 | 712.55M |
| August 07, 2026 | 707.25M |
| August 06, 2026 | 678.62M |
| August 05, 2026 | 660.59M |
| August 04, 2026 | 652.11M |
| August 03, 2026 | 558.07M |
| July 31, 2026 | 525.19M |
| July 30, 2026 | 530.67M |
| July 29, 2026 | 515.14M |
| July 28, 2026 | 547.11M |
| July 27, 2026 | 559.90M |
| July 24, 2026 | 542.54M |
| July 23, 2026 | 548.94M |
| July 22, 2026 | 542.54M |
| July 21, 2026 | 553.50M |
| July 20, 2026 | 537.06M |
| July 17, 2026 | 552.59M |
| July 16, 2026 | 586.38M |
| July 15, 2026 | 599.17M |
| July 14, 2026 | 579.08M |
| July 13, 2026 | 579.08M |
| July 10, 2026 | 595.52M |
| July 09, 2026 | 626.57M |
| July 08, 2026 | 626.57M |
| July 07, 2026 | 640.27M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cytokinetics, Inc. | 9.693B |
| ACADIA Pharmaceuticals, Inc. | 4.677B |
| Alnylam Pharmaceuticals, Inc. | 31.81B |
| Anika Therapeutics, Inc. | 282.11M |
| Savara, Inc. | 1.086B |
Market Cap Related Metrics
| PS Ratio | 5.492 |
| PEG Ratio | -0.0212 |
| Price to Book Value | 6.656 |
| Price | 6.775 |
| Earnings Yield | -2.89% |
| PEGY Ratio | -0.0212 |